Dr. Ullah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3401 N Broad St
Philadelphia, PA 19140Phone+1 215-707-1622
Summary
- Cardiology Fellow @Thomas Jefferson University Hospital, Philadelphia, PA, USA
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2013
Certifications & Licensure
- PA State Medical License 2021 - 2026
- MA State Medical License 2024 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Safety and Tolerability of Nitro for Radial Artery Dilation Start of enrollment: 2022 May 01
Roles: Contact
Publications & Presentations
PubMed
- Safety and Efficacy of Different Stent Strategies in Percutaneous Coronary Intervention: A Network Meta-Analysis.Waqas Ullah, Harigopal Sandhyavenu, Syeda Ramsha Zaidi, Mileydis Alonso, Muhammad Atif Khan
JACC. Advances. 2025-02-18 - Peri-Procedural Outcomes of Left Atrial Appendage Occlusion in Lower Versus Higher CHADS-VASc Score.Rafey Feroze, Yusef Saeed, Waqas Ullah, Nawaf Alhabdan, Alexander Cove
The American Journal of Cardiology. 2025-01-31 - Antiplatelet Strategy for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis.Waqas Ullah, Harigopal Sandhyavenu, Amro Taha, Smitha Narayana Gowda, Maryam Mukhtar
Journal of the American Heart Association. 2024-10-15
Press Mentions
- TAVR and PAD: What Cardiologists Need to KnowFebruary 6th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: